BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2019
View Archived Issues
RC-01 demonstrates promising efficacy in murine pneumonia and urinary tract infection models
Read More
Strictinin reduces TNBC proliferation, survival and motility via inhibition of ROR1
Read More
HMCES, in detail
Read More
Goldfish genome brings zebrafish insight
Read More
Results from phase II study of trabectedin in recurrent grade II or III meningioma
Read More
Hanmi presents phase I results for belvarafenib in patients with solid tumors
Read More
First-in-human data presented for SRA-737
Read More
Cerecor announces promising final results from phase I study of CERC-301
Read More
First patient enrolled in phase II study of rimegepant for refractory trigeminal neuralgia
Read More
Enrollment begins in phase III study of camrelizumab plus rivoceranib for HCC
Read More
Results from phase II study presented for sintilimab in patients with R/R ENKTL
Read More
SciFluor Life Sciences divulges KCNQ2/3 activators
Read More
Boehringer Ingelheim patents GluN2B negative allosteric modulators
Read More
Parkinson's disease starts in gut, moves to brain: study
Read More
GlaxoSmithKline synthesizes new IDO1 inhibitors
Read More
Esteve Pharmaceuticals patent describes analgesic agents
Read More
Shanghai Meiyue Biotech presents new thrombin inhibitors
Read More
European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma
Read More
Boston Biomedical to discontinue CanStem111P study of napabucasin in pancreatic cancer
Read More
Boehringer Ingelheim and Yuhan collaborate on GLP1R/FGF21R agonist for NASH
Read More
CD45 could be a novel target for B-cell malignancies
Read More
Holy Stone studies CA-102N in first-in-human trial for advanced solid tumors
Read More
Early diagnosis of X-linked myotubular myopathy in an infant
Read More
PTC Therapeutics and Odylia collaborate on gene therapies for rare inherited retinal diseases
Read More
CNOT2 deletion identified as responsible for the phenotypes of the 12q15 microdeletion syndrome
Read More
